David Michael Holtzman

David Michael Holtzman, MD

  • Neurology
  • Adult Neurology

Sees Patients For

Neurology, molecular biology, pharmacology, nervous system, Alzheimer's disease, memory, brain research, cerebral blood flow, metabolism, neuroscience, lipid research, neuron, mental retardation, Down's syndrome, neonatal hypoxic-ischemia, brain disorders, spinal fluid.

Patients Seen At

Hospital Affiliations

  • Barnes-Jewish Hospital

Board Certifications

  • Neurology

Academic Title(s)

Andrew B. and Gretchen P. Jones Professor of Neurology
Charlotte and Paul Hagemann Professor of Neurology
Chairman, Department of Neurology
Professor, Molecular Biology and Pharmacology
Neurologist-in-Chief, Barnes-Jewish Hospital

Languages

  • English

Education

Residency

1989 Neurology, University of California, San Francisco, California

Medical Degree

1985 Northwestern University, Chicago, Illinois

BS

1983 Science in Medical Education, Northwestern University, Chicago, Illinois

Research Interests

Underlying mechanisms that lead to Alzheimer's disease.

Publications & Research

Search PubMed for publications »

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Company Name: C2N DiagnosticsEquity: YesConsulting/Advisory Board: $40,000 - $59,999Reporting Date: 05/01/2021
Company Name: DenaliConsulting/Advisory Board: $10,000 - $19,999Reporting Date: 05/01/2021